| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |